The PARTNER trial of neoadjuvant olaparib in triple-negative breast cancer. Abraham JE, Pinilla K, Dayimu A, Grybowicz L, et al. Nature 2024 Apr 8. doi: 10.1038/s41586-024-07384.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Abraham JE, Pinilla K, Dayimu A, Grybowicz L, et al. The PARTNER trial of neoadjuvant olaparib in triple-negative breast cancer. Nature 2024 Apr 8. doi: 10.1038/s41586-024-07384.
PMID: 38588696